Average Co-Inventor Count = 4.89
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Medimmune Limited (30 from 541 patents)
2. Medlmmune Limited (2 from 6 patents)
3. Other (1 from 832,880 patents)
4. University of California (1 from 15,502 patents)
5. The Feinstein Institutes for Medical Research (1 from 153 patents)
32 patents:
1. 12428473 - Combination therapies using anti-pseudomonas PSL and PCRV binding molecules
2. RE49908 - Bispecific binding proteins and uses thereof
3. 11926657 - Neutralizing anti-influenza binding molecules and uses thereof
4. 11845782 - Relaxin fusion polypeptides and uses thereof
5. 11759526 - Method and molecules
6. 11634483 - Nucleic acids encoding anti-VEGF-A antibodies and uses thereof
7. 11566068 - Nucleic acids encoding bispecific anti-VEGF and anti-ANG2 antibodies and uses thereof
8. 11524993 - Neutralizing anti-influenza binding molecules and uses thereof
9. 11414477 - Methods for preparing antibodies with a defined glycosylation pattern
10. 11279759 - Bispecific binding proteins and uses thereof
11. 11203633 - Polynucleotides encoding antibodies or antigen binding fragments thereof that bind pseudomonas perv
12. 11192931 - Relaxin fusion polypeptides and uses thereof
13. 10919958 - Anti-VEGF-A antibodies and uses thereof
14. 10882897 - Neutralizing anti-influenza binding molecules and uses thereof
15. 10836819 - Anti-VEGF-A and anti-ANG2 antibodies and uses thereof